Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Impact on Early Stage and Outcomes-Comprehensive Review.

Indian J Surg Oncol

Department of Surgical Oncology and Robotic Surgery, HCG Bharath Cancer Hospital, Mysore, India.

Published: September 2024

Triple-negative breast cancer (TNBC) poses a significant challenge in clinical oncology due to its aggressive nature and limited targeted therapeutic options. Neoadjuvant chemotherapy (NACT) has emerged as a promising strategy in the management of early-stage TNBC. This literature review aims to provide an in-depth analysis of the role of NACT in TNBC, focusing on its impact on early-stage disease and associated outcomes. The review synthesizes evidence from recent studies, clinical trials, and meta-analyses to present a comprehensive overview of the current landscape of NACT in early-stage TNBC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11422321PMC
http://dx.doi.org/10.1007/s13193-024-02032-7DOI Listing

Publication Analysis

Top Keywords

neoadjuvant chemotherapy
8
triple-negative breast
8
breast cancer
8
early-stage tnbc
8
chemotherapy triple-negative
4
cancer impact
4
impact early
4
early stage
4
stage outcomes-comprehensive
4
outcomes-comprehensive review
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!